Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Manage your formulary budget
Proactively manage your pharmacy inventory
Find generic entry opportunities
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Method of in vitro fertilization|
|Abstract:||A method of in vitro fertilization therapy, which includes means for inducing ovulation by administering an exogenous human menopausal gonadotropin preparation and human chorionic gonadotropin, harvesting the mature follicles, combining the ovum with spermatazoa in vitro and transferring the conceptus into the uterus is improved by employing FSH as the exogenous human menopausal gonadotropin in the absence of exogenous LH.|
|Inventor(s):||Hodgen; Gary D. (Potomac, MD), Jones, Jr.; Howard W. (Norfolk, VA), Jones; Georgeanna S. (Norfolk, VA)|
|Assignee:||SErono Laboratories, Inc. (Randolph, MA)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Austria||64099||<disabled in preview>|
|Germany||3583081||<disabled in preview>|
|European Patent Office||0170502||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.